Graham Capital Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.4K | Buy |
+40,633
| New | +$89.4K | ﹤0.01% | 1175 |
|
|
2024
Q2 | – | Sell |
-62,106
| Closed | -$461K | – | 1092 |
|
|
2024
Q1 | $461K | Buy |
62,106
+46,725
| +304% | +$347K | 0.01% | 629 |
|
|
2023
Q4 | $156K | Sell |
15,381
-16,975
| -52% | -$172K | ﹤0.01% | 847 |
|
|
2023
Q3 | $252K | Sell |
32,356
-732
| -2% | -$5.71K | 0.01% | 764 |
|
|
2023
Q2 | $272K | Buy |
+33,088
| New | +$272K | 0.01% | 712 |
|
|
2022
Q4 | – | Sell |
-158,186
| Closed | -$1.94M | – | 1093 |
|
|
2022
Q3 | $1.94M | Buy |
158,186
+14,106
| +10% | +$173K | 0.08% | 226 |
|
|
2022
Q2 | $1.7M | Buy |
+144,080
| New | +$1.7M | 0.07% | 253 |
|
|
2022
Q1 | – | Sell |
-12,429
| Closed | -$329K | – | 910 |
|
|
2021
Q4 | $329K | Buy |
+12,429
| New | +$329K | 0.01% | 279 |
|